Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Aortic valve reconstruction with autologous pericardium in a patient with osteogenesis imperfecta.

Güllü AÜ, Senay S, Ozkan B, Kocyigit M, Alhan C.

J Surg Case Rep. 2018 Oct 5;2018(10):rjy251. doi: 10.1093/jscr/rjy251. eCollection 2018 Oct.

2.

Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial.

Stevens-Kroef MJ, Olde Weghuis D, ElIdrissi-Zaynoun N, van der Reijden B, Cremers EMP, Alhan C, Westers TM, Visser-Wisselaar HA, Chitu DA, Cunha SM, Vellenga E, Klein SK, Wijermans P, de Greef GE, Schaafsma MR, Muus P, Ossenkoppele GJ, van de Loosdrecht AA, Jansen JH.

Genes Chromosomes Cancer. 2017 Jul;56(7):524-534. doi: 10.1002/gcc.22455. Epub 2017 Mar 31.

PMID:
28236351
3.

Robotic mitral valve replacement for rheumatic mitral disease.

Senay S, Gullu AU, Alhan C.

Ann Cardiothorac Surg. 2017 Jan;6(1):64-66. doi: 10.21037/acs.2016.08.03. Review. No abstract available.

4.

Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes.

Cremers EM, Westers TM, Alhan C, Cali C, Visser-Wisselaar HA, Chitu DA, van der Velden VH, Te Marvelde JG, Klein SK, Muus P, Vellenga E, de Greef GE, Legdeur MC, Wijermans PW, Stevens-Kroef MJ, Silva-Coelho PD, Jansen JH, Ossenkoppele GJ, van de Loosdrecht AA; A study on behalf of the HOVON89 study group.

Haematologica. 2017 Feb;102(2):320-326. doi: 10.3324/haematol.2016.147843. Epub 2016 Sep 22.

5.

Good's syndrome: an uncommon cause of therapy-resistant diarrhoea.

Disselhorst MJ, Dickhoff C, Alhan C.

Neth J Med. 2016 Aug;74(7):309-12.

6.

Robotic Septal Myectomy and Mitral Valve Repair for Idiopathic Hypertrophic Subaortic Stenosis With Systolic Anterior Motion.

Bayburt S, Senay S, Gullu AU, Kocyigit M, Karakus G, Batur MK, Alhan C.

Innovations (Phila). 2016 Mar-Apr;11(2):146-9. doi: 10.1097/IMI.0000000000000249.

PMID:
27115534
7.

Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.

Cremers EMP, Westers TM, Alhan C, Cali C, Wondergem MJ, Poddighe PJ, Ossenkoppele GJ, van de Loosdrecht AA.

Eur J Cancer. 2016 Feb;54:49-56. doi: 10.1016/j.ejca.2015.11.013. Epub 2015 Dec 22.

PMID:
26720403
8.

Mirror Image Gerbode or Partial Atrioventricular Canal Defect?

Ariturk C, Gullu AU, Senay S, Okten EM, Toraman F, Karabulut EH, Melengic L, Alhan C.

Korean J Thorac Cardiovasc Surg. 2015 Dec;48(6):404-6. doi: 10.5090/kjtcs.2015.48.6.404. Epub 2015 Dec 5.

9.

Unrecognized indication for robot-assisted cardiac surgery: Patients with acute psychotic disorders.

Demirkilic U, Kadan M, Doganci S, Bolcal C, Yildirim V, Alhan C.

Minim Invasive Ther Allied Technol. 2016;25(2):117-9. doi: 10.3109/13645706.2015.1119701. Epub 2015 Dec 3.

PMID:
26635124
10.

Message From the MIRC President.

Alhan CH.

Innovations (Phila). 2015 Dec;10 Suppl 3:S1. doi: 10.1097/IMI.0000000000000207. No abstract available.

PMID:
26630555
11.

Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.

Alhan C, Westers TM, Cremers EM, Cali C, Ossenkoppele GJ, van de Loosdrecht AA.

Cytometry B Clin Cytom. 2016 Jul;90(4):358-67. doi: 10.1002/cyto.b.21333. Epub 2015 Dec 14.

12.

The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system.

Alhan C, Westers TM, Cremers EM, Cali C, Witte BI, Ossenkoppele GJ, van de Loosdrecht AA.

Leukemia. 2016 Mar;30(3):658-65. doi: 10.1038/leu.2015.295. Epub 2015 Oct 27.

PMID:
26503643
13.

Use of bone wax is related to increased postoperative sternal dehiscence.

Alhan C, Arıtürk C, Senay S, Okten M, Güllü AU, Kilic L, Karabulut H, Toraman F.

Kardiochir Torakochirurgia Pol. 2014 Dec;11(4):385-90. doi: 10.5114/kitp.2014.47337. Epub 2014 Nov 30.

14.

Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing.

Siler U, Paruzynski A, Holtgreve-Grez H, Kuzmenko E, Koehl U, Renner ED, Alhan C, de Loosdrecht AA, Schwäble J, Pfluger T, Tchinda J, Schmugge M, Jauch A, Naundorf S, Kühlcke K, Notheis G, Güngor T, Kalle CV, Schmidt M, Grez M, Seger R, Reichenbach J.

Curr Gene Ther. 2015;15(4):416-27.

PMID:
25981636
15.

Immunophenotyping for diagnosis and prognosis in MDS: ready for general application?

Cremers EM, Alhan C, Westers TM, Ossenkoppele GJ, van de Loosdrecht AA.

Best Pract Res Clin Haematol. 2015 Mar;28(1):14-21. doi: 10.1016/j.beha.2014.11.003. Epub 2014 Nov 11. Review.

PMID:
25659726
16.

Emergent endovascular repair of ruptured abdominal and thoracic aortic aneurysms in a single center: midterm outcomes.

Gŭllŭ AÜ, Burnaz T, Okten E, Senay S, Ariturk C, Toraman F, Kocyigit M, Yaylaci S, Karabulut E, Alhan C.

Chirurgia (Bucur). 2014 Nov-Dec;109(6):753-7.

17.

Robotic mitral valve replacement.

Senay S, Gullu AU, Kocyigit M, Degirmencioglu A, Karabulut H, Alhan C.

Multimed Man Cardiothorac Surg. 2014 Sep 16;2014. pii: mmu016. doi: 10.1093/mmcts/mmu016. Print 2014.

18.

Robotic atrial septal defect closure.

Senay S, Gullu AU, Kocyigit M, Degirmencioglu A, Karabulut H, Alhan C.

Multimed Man Cardiothorac Surg. 2014 Aug 7;2014. pii: mmu014. doi: 10.1093/mmcts/mmu014. Print 2014.

19.

Robotic mitral valve replacement for severe rheumatic mitral disease: perioperative technique, outcomes, and early results.

Senay S, Gullu AU, Kocyigit M, Degirmencioglu A, Kilic L, Karabulut H, Alhan C.

Innovations (Phila). 2014 Jul-Aug;9(4):292-6. doi: 10.1097/IMI.0000000000000078.

PMID:
25084245
20.

Utility of cerebral oxymetry for assessing cerebral arteriolar carbon dioxide reactivity during cardiopulmonary bypass.

Ariturk C, Okten M, Ozgen ZS, Erkek E, Uysal P, Gullu U, Senay S, Karabulut H, Alhan C, Toraman F.

Heart Surg Forum. 2014 Jun;17(3):E169-72. doi: 10.1532/HSF98.2014319.

PMID:
25002395
21.

High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes.

Alhan C, Westers TM, Cremers EM, Cali C, Witte BI, Ossenkoppele GJ, van de Loosdrecht AA.

Br J Haematol. 2014 Oct;167(1):100-9. doi: 10.1111/bjh.12994. Epub 2014 Jun 30.

PMID:
24976502
22.

Plasma omentin levels in drug-free patients with schizophrenia.

Yildirim O, Canan F, Tosun M, Kayka N, Tuman TC, Alhan C, Alcelik A.

Neuropsychobiology. 2014;69(3):159-64. doi: 10.1159/000360736. Epub 2014 May 16.

PMID:
24852382
23.

Right ventricular endomyocardial fibrosis mimicking Ebstein anomaly in a patient with Behçet's disease: case report and review of the literature.

Buturak A, Saygili O, Ulus S, Kalfa M, Karabulut H, Alhan C, Dagdelen S, Aksu K.

Mod Rheumatol. 2014 May;24(3):532-6. doi: 10.3109/14397595.2013.874731. Epub 2014 Feb 18. Review.

PMID:
24533554
24.

Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes.

Alhan C, Westers TM, van der Helm LH, Eeltink C, Huls G, Witte BI, Buchi F, Santini V, Ossenkoppele GJ, van de Loosdrecht AA.

Cytometry B Clin Cytom. 2014 May;86(3):207-15. doi: 10.1002/cyto.b.21160. Epub 2014 Jan 28.

25.

Endoscopic-assisted robotic aortic thrombectomy and aortobiiliac bypass: a case report.

Alhan C, Erguner I, Senay S, Kaya H, Gullu AU, Kocyigit M, Karahasanoglu T.

Ann Vasc Surg. 2014 Jul;28(5):1320.e5-8. doi: 10.1016/j.avsg.2013.11.009. Epub 2014 Jan 15.

PMID:
24440193
26.

Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes.

Alhan C, Westers TM, van der Helm LH, Eeltink C, Huls G, Witte BI, Buchi F, Santini V, Ossenkoppele GJ, van de Loosdrecht AA.

Cytometry B Clin Cytom. 2014 Jan 15. doi: 10.1002/cytob.21160. [Epub ahead of print]

PMID:
24431028
27.

The effect of mild left ventricular diastolic dysfunction on outcome after isolated coronary bypass surgery.

Değirmencioğlu A, Şenay Ş, Güllü Ü, Zencirci E, Karakuş G, Ugur M, Buturak A, Alhan C.

Kardiol Pol. 2014;72(6):541-5. doi: 10.5603/KP.a2013.0354. Epub 2014 Jan 10.

28.
29.

Intravenous leiomyoma with extension to the heart: a case report and review of the literature.

Demirkiran F, Sal V, Kaya U, Alhan C, Tokgozoglu N.

Case Rep Obstet Gynecol. 2013;2013:602407. doi: 10.1155/2013/602407. Epub 2013 Sep 29. Retraction in: Case Rep Obstet Gynecol. 2014;2014:674953.

30.

Leyla loop: a time-saving suture technique for robotic atrial closure.

Kiliç L, Şenay Ş, Ümit Güllü A, Alhan C.

Interact Cardiovasc Thorac Surg. 2013 Sep;17(3):579-80. doi: 10.1093/icvts/ivt231. Epub 2013 Jun 12.

31.

Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts.

van der Helm LH, Veeger NJ, Kooy Mv, Beeker A, de Weerdt O, de Groot M, Alhan C, Hoogendoorn M, Laterveer L, van de Loosdrecht AA, Koedam J, Vellenga E, Huls G.

Leuk Res. 2013 Aug;37(8):877-82. doi: 10.1016/j.leukres.2013.03.022. Epub 2013 Apr 28.

32.

Replacement of the ascending aorta for severe atherosclerosis during coronary artery bypass surgery.

Gullu AU, Okten EM, Akay MH, Senay S, Kocyigit M, Toraman F, Karabulut EH, Alhan C.

J Card Surg. 2012 Sep;27(5):538-42. doi: 10.1111/j.1540-8191.2012.01510.x.

PMID:
22978830
33.

Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program.

Abouyahya I, Alhan C, Westers TM, te Boekhorst PA, Kappers-Klunne MC, Coenen JL, Heyning FH, Huls GA, de Wolf JT, Imholz AL, Koene HR, Veth G, de Kruijf EJ, Muus P, Planken EV, Segeren CM, Vasmel WL, van der Velden AM, Velders GA, Koedam J, Ossenkoppele GJ, van de Loosdrecht AA.

Leuk Lymphoma. 2013 Apr;54(4):874-7. doi: 10.3109/10428194.2012.728702. Epub 2012 Sep 28. No abstract available.

PMID:
22971215
34.

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group.

van de Loosdrecht AA, Ireland R, Kern W, Della Porta MG, Alhan C, Balleisen JS, Bettelheim P, Bowen DT, Burbury K, Eidenschink L, Cazzola M, Chu SS, Cullen M, Cutler JA, Dräger AM, Feuillard J, Fenaux P, Font P, Germing U, Haase D, Hellström-Lindberg E, Johansson U, Kordasti S, Loken MR, Malcovati L, te Marvelde JG, Matarraz S, Milne T, Moshaver B, Mufti GJ, Nikolova V, Ogata K, Oelschlaegel U, Orfao A, Ossenkoppele GJ, Porwit A, Platzbecker U, Preijers F, Psarra K, Richards SJ, Subirá D, Seymour JF, Tindell V, Vallespi T, Valent P, van der Velden VH, Wells DA, de Witte TM, Zettl F, Béné MC, Westers TM.

Leuk Lymphoma. 2013 Mar;54(3):472-5. doi: 10.3109/10428194.2012.718341. Epub 2012 Sep 14. Review.

PMID:
22916713
35.

Transcatheter aortic valve implantation applications in Turkey; the role of the heart team approach.

Dağdelen S, Alhan C.

Anadolu Kardiyol Derg. 2012 Sep;12(6):531. doi: 10.5152/akd.2012.172. Epub 2012 Jun 22. No abstract available.

36.

Azacitidine differentially affects CD4(pos) T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromes.

Bontkes HJ, Ruben JM, Alhan C, Westers TM, Ossenkoppele GJ, van de Loosdrecht AA.

Leuk Res. 2012 Jul;36(7):921-30. doi: 10.1016/j.leukres.2012.03.026. Epub 2012 Apr 14.

37.

Efficiency of antibacterial suture material in cardiac surgery: a double-blind randomized prospective study.

Isik I, Selimen D, Senay S, Alhan C.

Heart Surg Forum. 2012 Feb;15(1):E40-5. doi: 10.1532/HSF98.20111106.

PMID:
22360905
38.

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study.

Della Porta MG, Picone C, Pascutto C, Malcovati L, Tamura H, Handa H, Czader M, Freeman S, Vyas P, Porwit A, Saft L, Westers TM, Alhan C, Cali C, van de Loosdrecht AA, Ogata K.

Haematologica. 2012 Aug;97(8):1209-17. doi: 10.3324/haematol.2011.048421. Epub 2012 Feb 7.

39.

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group.

Westers TM, Ireland R, Kern W, Alhan C, Balleisen JS, Bettelheim P, Burbury K, Cullen M, Cutler JA, Della Porta MG, Dräger AM, Feuillard J, Font P, Germing U, Haase D, Johansson U, Kordasti S, Loken MR, Malcovati L, te Marvelde JG, Matarraz S, Milne T, Moshaver B, Mufti GJ, Ogata K, Orfao A, Porwit A, Psarra K, Richards SJ, Subirá D, Tindell V, Vallespi T, Valent P, van der Velden VH, de Witte TM, Wells DA, Zettl F, Béné MC, van de Loosdrecht AA.

Leukemia. 2012 Jul;26(7):1730-41. doi: 10.1038/leu.2012.30. Epub 2012 Feb 6.

PMID:
22307178
40.

Is increased perfusion pressure really necessary during cardiopulmonary bypass?

Alhan CH, Toraman F, Karabulut H.

Eur J Cardiothorac Surg. 2012 May;41(5):1213-4; author reply 1214. doi: 10.1093/ejcts/ezr172. Epub 2011 Dec 21. No abstract available.

PMID:
22219454
41.

Stroke after coronary bypass surgery is mainly related to diffuse atherosclerotic disease.

Senay S, Toraman F, Akgün Y, Aydin E, Karabulut H, Alhan C, Sarioglu T.

Heart Surg Forum. 2011 Dec;14(6):E366-72. doi: 10.1532/HSF98.20111031.

PMID:
22167763
42.

A simple method for occlusion of both venae cavae in total cardiopulmonary bypass for robotic surgery.

Gullu AU, Senay S, Kocyigit M, Alhan C.

Interact Cardiovasc Thorac Surg. 2012 Feb;14(2):138-9. doi: 10.1093/icvts/ivr057. Epub 2011 Nov 23.

43.

Acute left main coronary artery occlusion following TAVI and emergency solution.

Dağdelen S, Karabulut H, Alhan C.

Anadolu Kardiyol Derg. 2011 Dec;11(8):747-8. doi: 10.5152/akd.2011.204. Epub 2011 Dec 3. No abstract available.

44.

Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: report from the Dutch Working Party on Flow Cytometry in MDS.

Westers TM, van der Velden VH, Alhan C, Bekkema R, Bijkerk A, Brooimans RA, Cali C, Dräger AM, de Haas V, Homburg C, de Jong A, Kuiper-Kramer PE, Leenders M, Lommerse I, te Marvelde JG, van der Molen-Sinke JK, Moshaver B, Mulder AB, Preijers FW, Schindhelm RK, van der Sluijs A, van Wering ER, Westra AH, van de Loosdrecht AA; Working Party on Flow Cytometry in MDS of Dutch Society of Cytometry (NVC).

Leuk Res. 2012 Apr;36(4):422-30. doi: 10.1016/j.leukres.2011.09.015. Epub 2011 Oct 6.

PMID:
21982641
45.

Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme.

van der Helm LH, Alhan C, Wijermans PW, van Marwijk Kooy M, Schaafsma R, Biemond BJ, Beeker A, Hoogendoorn M, van Rees BP, de Weerdt O, Wegman J, Libourel WJ, Luykx-de Bakker SA, Minnema MC, Brouwer RE, Croon-de Boer F, Eefting M, Jie KS, van de Loosdrecht AA, Koedam J, Veeger NJ, Vellenga E, Huls G.

Br J Haematol. 2011 Dec;155(5):599-606. doi: 10.1111/j.1365-2141.2011.08893.x. Epub 2011 Oct 8.

PMID:
21981697
46.

Interrupted aortic arch or extreme coarctation? A case report and review of the literature.

Teskin O, Gullu AU, Senay S, Okten EM, Alhan C.

Heart Surg Forum. 2011 Jun;14(3):E188-91. doi: 10.1532/HSF98.20101100. Review.

PMID:
21676686
47.

Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy.

Aggarwal S, van de Loosdrecht AA, Alhan C, Ossenkoppele GJ, Westers TM, Bontkes HJ.

Br J Haematol. 2011 Jun;153(5):568-81. doi: 10.1111/j.1365-2141.2011.08683.x. Epub 2011 Apr 13. Review.

PMID:
21488861
48.

Validation of the EuroSCORE risk models in Turkish adult cardiac surgical population.

Akar AR, Kurtcephe M, Sener E, Alhan C, Durdu S, Kunt AG, Güvenir HA; Group for the Turkish Society of Cardiovascular Surgery and Turkish Ministry of Health.

Eur J Cardiothorac Surg. 2011 Sep;40(3):730-5. doi: 10.1016/j.ejcts.2011.01.002. Epub 2011 Feb 20.

PMID:
21342767
49.

Readmission to the intensive care unit after fast-track cardiac surgery: an analysis of risk factors and outcome according to the type of operation.

Toraman F, Senay S, Gullu U, Karabulut H, Alhan C.

Heart Surg Forum. 2010 Aug;13(4):E212-7. doi: 10.1532/HSF98.20101009.

PMID:
20719721
50.

Efficiency of preoperative tranexamic Acid in coronary bypass surgery: an analysis correlated with preoperative clopidogrel use.

Senay S, Toraman F, Karabulut H, Alhan C.

Heart Surg Forum. 2010 Jun;13(3):E149-54. doi: 10.1532/HSF98.20091176.

PMID:
20534413

Supplemental Content

Support Center